Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, today announced that it has submitted applications to the U.S. Drug E ...
Federal rescheduling could end a tax structure that made legal cannabis look far less profitable than it actually was. Here's ...
TSA updated its website after federal reclassification, but attorneys say there are still risks and unanswered questions for ...
The use of cannabis in nursing homes and assisted living facilities is an ongoing, complex issue driven by a conflict between state-level legalization and ...
Supporters said the legislation is partly intended to help smaller cannabis operators and social equity businesses that ...
EURweb on MSN
From cannabis to marijuana: The racializing of weed
*America did not merely criminalize a plant. It criminalized a people. Before “marijuana” became America’s most politically ...
The federal government’s reclassification of medical marijuana products as Schedule III drugs doesn’t federally legalize marijuana, but it might extend tax breaks to some cannabis businesses. ...
Curaleaf will execute a 1-for-3 reverse stock split positioning it to uplist to a U.S. stock exchange cannabis rescheduling creates an opening to do so.
Operators in states that have both medical and adult-use would have to separate the licenses to register their companies with ...
State lawmakers could pass a bill in the final days of the spring session to create new regulations for cannabis and hemp.
For decades, cannabis has occupied one of the most restrictive positions in federal drug policy, classified as a Schedule I substance under the Controlled Substances Act (CSA), alongside drugs deemed ...
For nearly three decades, the American cannabis industry has existed in a condition that can only be described as legally schizophrenic. States have licensed, taxed, regulated, insured, zoned, audited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results